# Oruka Therapeutics, Inc.: Form 8-K, filed Feb 5, 2025

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: 8-K
- Filed: 2025-02-05
- Accepted by EDGAR: Feb 5, 2025, 16:00 ET
- Period: 2025-02-04
- Accession: 0001213900-25-010525
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000121390025010525/ea0229970-8k_oruka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000121390025010525/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000121390025010525/ea0229970-8k_oruka.htm

Filed Feb 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-010525. Last ingested by Listed: Nov 10, 2026, 01:43 ET. No prices; not investment advice.